Crossmark

Evidence-Based Guidelines for Drug Interaction Studies: Model-Informed Time Course of Intestinal and Hepatic CYP3A4 Inhibition by Clarithromycin

Published Online: 2021-08-31

Published Print: 2021-09

Authors

Kapetas, Asha J

Abuhelwa, Ahmad Y

Sorich, Michael J

McKinnon, Ross A

Rodrigues, A David

Rowland, Andrew

Hopkins, Ashley M
License Information

Text and Data Mining valid from 2021-08-31

Version of Record valid from 2021-08-31
More Information

Article History

Received: 22 April 2021

Accepted: 29 July 2021

First Online: 31 August 2021

Declarations

:

: A.D.R. is an employee and stockholder of Pfizer Inc. A.R. and M.J.S. are recipients of unrelated research support from Pfizer Inc. All authors declare that there are no competing interests.

Document is current